Nighttime Cough-kids Solution
NDC Package 69676-0088-9

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Nighttime Cough-kids (chlorpheniramine maleate, dextromethorphan hbr) solution is uses• temporarily relieves cough due to minor throat and bronchial irritation as may occur with a cold• temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: • runny nose • sneezing • itchy, watery eyes • itching of the nose or throat. This formulation utilizes a solution delivery system. Marketed by Genexa, this product is identified by NDC 69676-0088 and is authorized under FDA application M012.

Identification & Billing

NDC Package Code
69676-0088-9
Package Description
1 BOTTLE in 1 CARTON / 118 mL in 1 BOTTLE
Product Code
69676-0088
11-Digit Billing Format
69676008809
RxNorm Crosswalk
  • RxCUI: 1111440 - chlorpheniramine maleate 1 MG / dextromethorphan HBr 7.5 MG in 5 mL Oral Solution
  • RxCUI: 1111440 - chlorpheniramine maleate 0.2 MG/ML / dextromethorphan hydrobromide 1.5 MG/ML Oral Solution
  • RxCUI: 1111440 - chlorpheniramine maleate 1 MG / dextromethorphan hydrobromide 7.5 MG per 5 ML Oral Solution
  • RxCUI: 1111440 - chlorpheniramine maleate 2 MG / dextromethorphan hydrobromide 15 MG per 10 ML Oral Solution

Clinical Specifications

Proprietary Name
Nighttime Cough-kids
Non-Proprietary Name
Chlorpheniramine Maleate, Dextromethorphan Hbr
Substance Name
Chlorpheniramine Maleate; Dextromethorphan Hydrobromide
Dosage Form
Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Uses• temporarily relieves cough due to minor throat and bronchial irritation as may occur with a cold• temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: • runny nose • sneezing • itchy, watery eyes • itching of the nose or throat

Regulatory & Marketing

Labeler Name
Genexa
Product Type
Human Otc Drug
FDA Application #
M012
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
05-06-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69676-0088-9 identifies a specific commercial package of 1 bottle in 1 carton / 118 ml in 1 bottle of Nighttime Cough-kids, a human over the counter drug labeled by Genexa. This solution is formulated for oral use and contains chlorpheniramine maleate; dextromethorphan hydrobromide as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Genexa on May 06, 2025. The current certification is valid through December 31, 2026.

How is this Genexa product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69676008809. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
69676-0088-9
11-Digit CMS (5-4-2)
69676-0088-09

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.